World
Brazil Health Regulator Rejects Russia's Sputnik Vaccine
Anvisa's board voted unanimously not to approve the Russian vaccine after technical staff had highlighted "inherent risks" and "serious" defects, citing a lack of information guaranteeing its safety, quality and effectiveness.